Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Sanofi to buy Chattem for $1.8bn, plus debt

Executive Summary

Giving it a presence in the US over-the-counter market, Sanofi-Aventis will acquire all of public company Chattem's outstanding shares for $93.50 each (a 36% premium) in a deal valued at about $1.8bn, plus the assumption of $300mm in debt.
Deal Industry
  • Pharmaceuticals
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Full Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register